Humana Inc HUM delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.
- Reports adjusted EPS of $3.18, beats by $0.03.
- Delivers revenue of $13.69 billion, tops by $0.28 billion.
- Expects full adjusted EPS to be about $9.50 versus Street expectations of $9.51.
- Share buyback program is suspended since July 2, 2015, pending the transaction with Aetna.
Humana’s SVP and CFO, Brian Kane, said, “We are pleased that our third-quarter results enable us to reaffirm our recently-raised EPS guidance for 2016, which includes two meaningful guidance increases during the course of the year. These increases are largely attributable to our better-than-expected performance in Medicare Advantage and Healthcare Services and we believe our performance positions us well for 2017.”
The stock closed at $165.31 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.